Pharmacologic Treatment Options for Hypoactive Sexual Desire Disorder
| Autor: | Glenn D. Braunstein, Sheila Y Bolour |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Gynecology
medicine.medical_specialty 030219 obstetrics & reproductive medicine business.industry medicine.medical_treatment Female sexual dysfunction Testosterone (patch) Hypoactive sexual desire disorder General Medicine Tibolone medicine.disease Buspirone 03 medical and health sciences Sexual desire 0302 clinical medicine Sexual dysfunction medicine 030212 general & internal medicine Hormone therapy medicine.symptom business Psychiatry medicine.drug |
| Zdroj: | Women's Health. 1:263-277 |
| ISSN: | 1745-5065 |
| DOI: | 10.2217/17455057.1.2.263 |
| Popis: | Hypoactive sexual desire disorder is the most common cause of sexual dysfunction in women. According to a national survey, approximately a third of all women experience low sexual desire. The etiology of the disorder is often multifactorial. Research in treatment options for hypoactive sexual desire disorder is limited. In this article, treatment options including sex therapy, hormone therapy (estrogen, testosterone, dehydroepiandrosterone, tibolone), non-hormonal medical therapies (buproprion, buspirone, phosphodiesterase-5 inhibitors, amantadine and apomorphine) and herbal therapies (Avlimil®, Arginmax®, Zestra®, yohimbine and Ginkgo biloba) are reviewed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|